Skip to main content
. 2016 Jan 25;12(1):e1005395. doi: 10.1371/journal.ppat.1005395

Fig 1. Detected peptides in amniotic fluid and differences between symptomatic and asymptomatic cases in the discovery cohort.

Fig 1

(A) Representation of 4076 peptides, detected in all amniotic fluid samples (n = 47) by CE-MS. Each peptide was identified by a unique identifier based on the migration time (min) and specific mass (kDa), with a peak height representing the relative abundance. (B) In the discovery cohort, 76 amniotic fluid peptides were identified as differentially secreted between symptomatic and asymptomatic patients. (C) Cross-validation score of a SVM peptide classifier called CMV34 consisting of 34 of the 37 sequenced peptides obtained from the analysis of the discovery cohort. ***p<0.0001, Mann-Whitney test for independent samples. Asympt., asymptomatic; Sympt., symptomatic.